These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18794797

  • 1. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J, Palma E, Gibo DM, Ringler S, Turner CP, Debinski W.
    Oncogene; 2008 Dec 11; 27(58):7260-73. PubMed ID: 18794797
    [Abstract] [Full Text] [Related]

  • 2. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J, Gibo DM, Stanton C, Debinski W.
    Mol Cancer Res; 2005 Oct 11; 3(10):541-51. PubMed ID: 16254188
    [Abstract] [Full Text] [Related]

  • 3. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J, Debinski W.
    Mol Cancer Res; 2008 Dec 11; 6(12):1795-806. PubMed ID: 19074825
    [Abstract] [Full Text] [Related]

  • 4. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M, Vemula SV, Sharma A, Ahi YS, Mittal S, Bangari DS, Mittal SK.
    J Gene Med; 2012 Feb 11; 14(2):77-89. PubMed ID: 22228563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells.
    Wykosky J, Gibo DM, Debinski W.
    Mol Cancer Ther; 2007 Dec 11; 6(12 Pt 1):3208-18. PubMed ID: 18089715
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor.
    Lema Tomé CM, Palma E, Ferluga S, Lowther WT, Hantgan R, Wykosky J, Debinski W.
    J Biol Chem; 2012 Apr 20; 287(17):14012-22. PubMed ID: 22362770
    [Abstract] [Full Text] [Related]

  • 9. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
    Nasreen N, Mohammed KA, Lai Y, Antony VB.
    Cancer Lett; 2007 Dec 18; 258(2):215-22. PubMed ID: 17949899
    [Abstract] [Full Text] [Related]

  • 10. The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells.
    Lee SH, Kang SH, Han MS, Kwak JW, Kim HG, Lee TH, Lee DB, Kim TH.
    Front Immunol; 2021 Dec 18; 12():793517. PubMed ID: 34975898
    [Abstract] [Full Text] [Related]

  • 11. Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.
    Greene AC, Lord SJ, Tian A, Rhodes C, Kai H, Groves JT.
    Biophys J; 2014 May 20; 106(10):2196-205. PubMed ID: 24853748
    [Abstract] [Full Text] [Related]

  • 12. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
    Rodriguez S, Rudloff S, Koenig KF, Karthik S, Hoogewijs D, Huynh-Do U.
    Pflugers Arch; 2016 Aug 20; 468(8):1433-48. PubMed ID: 27228995
    [Abstract] [Full Text] [Related]

  • 13. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
    Noblitt LW, Bangari DS, Shukla S, Knapp DW, Mohammed S, Kinch MS, Mittal SK.
    Cancer Gene Ther; 2004 Nov 20; 11(11):757-66. PubMed ID: 15359289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
    Xu Q, Lin WC, Petit RS, Groves JT.
    Biophys J; 2011 Dec 07; 101(11):2731-9. PubMed ID: 22261062
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
    Su J, Ji XB, Xie JH, Li W.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec 07; 51(12):929-936. PubMed ID: 27978884
    [Abstract] [Full Text] [Related]

  • 20. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
    Larsen AB, Stockhausen MT, Poulsen HS.
    Cell Signal; 2010 Apr 07; 22(4):636-44. PubMed ID: 19948216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.